Report of Foreign Issuer Pursuant to Rule 13a-16 or 15d-16 (6-k)
28 February 2023 - 8:06AM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
REPORT OF FOREIGN PRIVATE
ISSUER
PURSUANT TO RULE 13a-16
OR 15d-16 OF THE
SECURITIES EXCHANGE ACT
OF 1934
For the month of
February, 2023
Commission File
Number: 001-39446
CureVac N.V.
(Exact Name of Registrant as Specified in Its
Charter)
Friedrich-Miescher-Strasse 15, 72076
Tübingen, Germany
+49 7071 9883 0
(Address of principal executive office)
Indicate by check mark whether the registrant files
or will file annual reports under cover of Form 20-F or Form 40-F:
Form
20-F x
Form
40-F ¨
On February 27, 2023, CureVac N.V. (the “Company”)
convened the extraordinary general meeting of shareholders to be held on March 28, 2023 and made available to its shareholders certain
other materials in connection with such meeting.
The information in this Form 6-K (including Exhibit
99.1) shall not be deemed “filed” for purposes of Section 18 of the Securities Exchange Act of 1934 (the “Exchange Act”)
or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Securities
Act of 1933 or the Exchange Act.
SIGNATURES
Pursuant to the requirements of the Securities
Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| |
CUREVAC N.V. |
| |
|
|
| |
By: |
/s/ Franz-Werner Haas, LLD, LLM |
| |
|
Chief Executive Officer |
Date: February 27, 2023
EXHIBIT INDEX
CureVac NV (NASDAQ:CVAC)
Historical Stock Chart
From May 2024 to Jun 2024
CureVac NV (NASDAQ:CVAC)
Historical Stock Chart
From Jun 2023 to Jun 2024
